Electra Therapeutics (ETRA) vs Solid Biosciences (SLDB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Solid Biosciences is the larger company by market cap ($731.3 million vs $571.8 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETRA | SLDB |
|---|---|---|
| Share price | $9.11 | $6.82 |
| Market cap | $571.81M | $731.28M |
| 1-day change | -0.55% | -0.44% |
| YTD return | — | +21.45% |
| 1-year return | — | +24.09% |
| 5-year return | — | -79.70% |
| EPS (TTM) | $-2.65 | $-1.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.50 | $11.45 |
| 52-week low | $8.63 | $3.79 |
| Distance from 52-week high | -41.23% | -40.44% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +173.02% |
| Average volume | 948.89K | 1.09M |
| Shares outstanding | 62.77M | 107.23M |
| Employees | 46 | 121 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
About Solid Biosciences
SLDB stock →Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 121 employees
ETRA vs SLDB FAQ
Which is bigger, Electra Therapeutics or Solid Biosciences?
Solid Biosciences (SLDB) is larger, with a market capitalization of $731.28M compared with $571.81M for Electra Therapeutics (ETRA).
Are Electra Therapeutics and Solid Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.